Literature DB >> 21253734

Rheumatic complications of long term treatment with hemodialysis.

Nessrine Akasbi1, Tarik Sqalli Houssaini, Latifa Tahiri, Hicham Hachimi, Chakib El Maaroufi, Randa El Youbi, Mohammed Arrayhani, Taoufik Harzy.   

Abstract

Patients undergoing hemodialysis therapy develop serious osteoarticular diseases. The treatment is based on prevention. The aim of our study is to determine the frequency and the associated factors to the rheumatic manifestations in hemodialysis patients. A cross-sectional study was conducted, including all hemodialysed patients in our dialysis unit. Information was obtained from patients' symptoms, examination findings, and biological and radiological signs. The frequency of symptoms was 70% in our patients. It was proportional to the duration of hemodialysis and number of hemodialysis sessions per week. Early transplantation is of course a plausible solution, but other therapies such as improved dialysis must be considered.

Entities:  

Mesh:

Year:  2011        PMID: 21253734     DOI: 10.1007/s00296-010-1756-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients.

Authors:  Y Koda; S Nishi; S Miyazaki; S Haginoshita; T Sakurabayashi; M Suzuki; S Sakai; Y Yuasa; Y Hirasawa; T Nishi
Journal:  Kidney Int       Date:  1997-10       Impact factor: 10.612

Review 2.  Epidemiology of hip and knee osteoarthritis.

Authors:  D T Felson
Journal:  Epidemiol Rev       Date:  1988       Impact factor: 6.222

3.  Joint problems in patients on maintenance hemodialysis.

Authors:  E A Brown; P E Gower
Journal:  Clin Nephrol       Date:  1982-11       Impact factor: 0.975

4.  Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study.

Authors:  D T Felson; Y Zhang; M T Hannan; A Naimark; B Weissman; P Aliabadi; D Levy
Journal:  Arthritis Rheum       Date:  1997-04

5.  Patients surviving more than 10 years on haemodialysis. The natural history of the complications of treatment.

Authors:  S A Harris; E A Brown
Journal:  Nephrol Dial Transplant       Date:  1998-05       Impact factor: 5.992

6.  Patients undergoing dialysis therapy for 30 years or more survive with serious osteoarticular disorders.

Authors:  S Yamamoto; J J Kazama; H Maruyama; S Nishi; I Narita; F Gejyo
Journal:  Clin Nephrol       Date:  2008-12       Impact factor: 0.975

7.  Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years.

Authors:  Shigeru Otsubo; Naoki Kimata; Ichiro Okutsu; Kazunori Oshikawa; Syuitsu Ueda; Hisayuki Sugimoto; Michihiro Mitobe; Keiko Uchida; Kimiko Otsubo; Kosaku Nitta; Takashi Akiba
Journal:  Nephrol Dial Transplant       Date:  2008-12-18       Impact factor: 5.992

8.  Factors associated with hip osteoarthritis: data from the First National Health and Nutrition Examination Survey (NHANES-I).

Authors:  S Tepper; M C Hochberg
Journal:  Am J Epidemiol       Date:  1993-05-15       Impact factor: 4.897

9.  Hemodialysis-related lesions of the hand.

Authors:  G Asencio; C Rigout; P Ramperez; B Branger; R Oules; R Bertin; B Megy; C Leonardi
Journal:  Rev Rhum Engl Ed       Date:  1995-04

10.  Association between metabolic factors and knee osteoarthritis in women: the Chingford Study.

Authors:  D J Hart; D V Doyle; T D Spector
Journal:  J Rheumatol       Date:  1995-06       Impact factor: 4.666

View more
  2 in total

1.  Musculoskeletal Disorders and Associated Factors Among Patients with Chronic Kidney Disease Attending at Saint Paul Hospital, Addis Ababa, Ethiopia.

Authors:  Sisay Deme; Berihu Fisseha; Gebreslassie Kahsay; Haimanot Melese; Abayneh Alamer; Sileshi Ayhualem
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-08-04

2.  Asymptomatic secondary hyperparathyroidism can mimic sacroiliitis on computed tomography.

Authors:  Virginie Kreutzinger; Torsten Diekhoff; Lutz Liefeldt; Denis Poddubnyy; Kay Geert A Hermann; Katharina Ziegeler
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.